1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Patient demographicsa
Chondrosarcoma Chordoma Metastasis No. of patients 15 14 30 Sex (male/total) 9/15 6/14 11/30 Age (yr) 62 (46–70) 47 (32–58) 61 (47–70) Maximum axial diameter (mm) 29.5 (24–36) 33 (24–40) 18.5 (15–23) Primary cancer type NA NA 11 Breast, 6 lung, 6 malignant melanoma,4 head and neck, 2 sarcoma, 1 kidney
Note:—NA indicates not applicable.
↵a Values are presented as the median (IQR).